In recognition of AMR Awareness Week, PhageEU hosted another successful webinar, which took place on 20th November 2025.PhageEU members shared some recent developments and innovations in the area of phage…
At the occasion of World Phage Day, PhageEU launched its PhageEU Academy! This was a series of online workshops to provide decision makers and stakeholders with evidence-based information about bacteriophages…
We are pleased to announce the latest edition of Phage EU Insights, now available to read. This issue marks a significant milestone: PhageEU’s first anniversary and showcases the rapid growth…
A new European Biotech Act was announced in the political guidelines for the European Commission 2024-2029. This new act should make it easier to bring biotech from the laboratory to…
The COVID-19 pandemic demonstrated the need to reinforce the EU’s health security framework and the added value of EU-level coordination to prepare and respond to serious cross-border health threats. Extreme…
PhageEU has published its position with regards to the Pharmaceutical Package. With its recommendations for decision makers, PhageEU aims at making sure, that phage therapies are recognised within key areas of…
Sepsis is the most severe complication of infections and a leading cause of preventable deaths and disability in Europe. Every minute in Europe more than one person, amongst the 3.4…
Brussels, 30th January 20252024 was a milestone year for PhageEU. It has officially incorporated as non-governmental organisation and with its seat and secretariat in Brussels, PhageEU is well equipped to…
PhageEU is pleased to announce the release of our 2024 Year in Review Newsletter, highlighting the organisation's milestone achievements. The newsletter details our formal incorporation as an non-governmental organisation in…
Brussels, 11th July 2024Bacteriophages offer solutions to fight AMR and reduce the use of antibiotics. This is especially important now, when antimicrobial resistance (AMR) is on its rise despite various…